Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Appl Microbiol ; 131(5): 2567-2578, 2021 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-33884721

RESUMO

AIMS: Assess the feasibility of using light from artificial sun lamps to decontaminate N95 filtering facepiece respirators (FFRs) contaminated with SARS-CoV-2. METHODS AND RESULTS: FFR coupons or whole FFRs contaminated with 5 log10 TCID50 (target concentration) SARS-CoV-2 in culture media, simulated saliva, or simulated lung fluid were dried for 1-2 h, then exposed to light from tanning and horticulture lamps to assess decontamination. Exposed coupons and whole FFRs showed SARS-CoV-2 inactivation for all matrices tested. Furthermore, FFRs still met performance specifications after five decontamination cycles. CONCLUSIONS: It is feasible that artificial sunlight from these sun lamps can be used to decontaminate FFRs provided the UV dose is sufficient and the light is unobstructed. Furthermore, decontamination can be performed up to five times without degrading FFR performance. SIGNIFICANCE AND IMPACT OF THE STUDY: This research shows a proof of principle that artificial sun lamps may be an option to decontaminate SARS-CoV-2 on N95 FFRs. UV doses required for inactivation to levels below detection ranged from 4 to 37·8 J cm-2 depending on the light source, virus matrix and FFR type.


Assuntos
COVID-19 , Reutilização de Equipamento , Descontaminação , Humanos , Respiradores N95 , SARS-CoV-2
2.
Lett Appl Microbiol ; 72(4): 366-374, 2021 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-33347637

RESUMO

Decontamination of N95 filtering facepiece respirators (FFRs) is a crisis capacity strategy allowed when there are known shortages of FFRs. The application of moist heat is one decontamination method that has shown promise and is the approach approved in the Steris Steam Emergency Use Authorization (EUA). This effort examines the use of multicookers to apply moist heat, as they are available in retail stores and more affordable than methods requiring more sophisticated equipment. Four of five multicooker models examined met the acceptance criteria for the test and one model was selected for inactivation testing. Tests were performed on four different FFR models with SARS-CoV-2 suspended in culture media, simulated saliva or simulated lung fluid. Moist heat treatment reduced recoverable titres of SARS-CoV-2 virus to levels below the limit of detection in all tests. Furthermore, these four FFR models showed no loss in collection efficiency, inhalation resistance or visual damage after up to 10 decontamination cycles. Two (2) FFR models showed a slight change in strap elasticity (<9%). These data show that moist heat treatment using a multicooker is a viable option for FFR decontamination in a crisis capacity strategy.


Assuntos
COVID-19/prevenção & controle , Descontaminação/métodos , Reutilização de Equipamento , Temperatura Alta , Respiradores N95 , Humanos , SARS-CoV-2/isolamento & purificação
3.
J Intellect Disabil Res ; 41 ( Pt 3): 273-7, 1997 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-9219078

RESUMO

The existing literature regarding neuroleptic malignant syndrome (NMS) amongst people with learning disabilities is limited. We describe three case reports of people with learning disabilities from the same geographical area who developed NMS within 3 weeks of each other. This was during the hottest part of a very hot summer. The presentation of NMS is discussed. The importance of carers attending to adequate hydration for people with learning disabilities and poor communication skills during the summer months is stressed.


Assuntos
Antipsicóticos/efeitos adversos , Temperatura Alta/efeitos adversos , Deficiência Intelectual/tratamento farmacológico , Síndrome Maligna Neuroléptica/etiologia , Estações do Ano , Adolescente , Adulto , Antipsicóticos/administração & dosagem , Diagnóstico Diferencial , Quimioterapia Combinada , Feminino , Humanos , Deficiência Intelectual/psicologia , Masculino , Síndrome Maligna Neuroléptica/diagnóstico , Síndrome Maligna Neuroléptica/prevenção & controle , Instituições Residenciais , Fatores de Risco
5.
Am Pharm ; NS20(10): 43-9, 1980 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-7435368
6.
Contemp Pharm Pract ; 3(4): 268-70, 1980.
Artigo em Inglês | MEDLINE | ID: mdl-10248869

RESUMO

Community pharmacists can provide pharmaceutical services to the health maintenance organization (HMO) patient on a cost-effective, competitive basis. Reimbursement based on usual and customary fees has proven to be an attractive method of payment not only to the participating pharmacists, but to the HMO administration as well. State pharmaceutical associations can play an integral role in developing, administering, and monitoring the pharmaceutical component of an HMO. A sharing of the financial risk encourages pharmacists to act as prudent purchasers of the drug product to be dispensed to HMO patients.


Assuntos
Sistemas Pré-Pagos de Saúde , Seguro de Serviços Farmacêuticos , Assistência Farmacêutica/economia , Minnesota
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...